AACR logo

More articles from Research Article

A cell-based MAPK reporter assay reveals synergistic MAPK pathway activity suppression by MAPK inhibitor combination in BRAF-driven pediatric low-grade glioma cells
Diren Usta, Romain Sigaud, Juliane L. Buhl, Florian Selt, Viktoria Marquardt, David Pauck, Jennifer Jansen, Stefan Pusch, Jonas Ecker, Thomas Hielscher, Johanna Vollmer, Alexander C. Sommerkamp, Tobias Rubner, Darren Hargrave, Cornelis M. van Tilburg, Stefan M. Pfister, David T.W. Jones, Marc Remke, Tilman Brummer, Olaf Witt, Till Milde

Molecular Cancer Therapeutics Jan 2020, molcanther.1021.2019; DOI: 10.1158/1535-7163.MCT-19-1021
Pathway-specific genome editing of PI3K/mTOR tumor suppressor genes reveals that PTEN loss contributes to cetuximab resistance in head and neck cancer
Hiroki Izumi, Zhiyong Wang, Yusuke Goto, Toshinori Ando, Xingyu Wu, Xuefeng Zhang, Hua Li, Daniel E Johnson, Jennifer R. Grandis, J. Silvio Gutkind

Molecular Cancer Therapeutics Jan 2020, molcanther.1036.2019; DOI: 10.1158/1535-7163.MCT-19-1036
Inhibition of tumor cell growth and cancer stem cell expansion by a bispecific antibody targeting EGFR and HER3
Alexander Rau, Wolfgang S. Lieb, Oliver Seifert, Jonas Honer, Dennis Birnstock, Fabian Richter, Nadine Aschmoneit, Monilola A Olayioye, Roland E. Kontermann

Molecular Cancer Therapeutics Jan 2020, molcanther.1095.2019; DOI: 10.1158/1535-7163.MCT-19-1095
Perhexiline demonstrates FYN-mediated anti-tumor activity in glioblastoma
Shiva Kant, Pravin Kesarwani, Anthony R. Guastella, Praveen Kumar, Stewart F Graham, Katie L Buelow, Ichiro Nakano, Prakash Chinnaiyan

Molecular Cancer Therapeutics Jan 2020, molcanther.1047.2019; DOI: 10.1158/1535-7163.MCT-19-1047
Cross-resistance among next generation anti-androgen drugs through the AKR1C3/AR-V7 axis in advanced prostate cancer
Jinge Zhao, Shu Ning, Wei Lou, Joy C Yang, Cameron M. Armstrong, Alan P. Lombard, Leandro S D'Abronzo, Christopher P Evans, Allen C. Gao, Chengfei Liu

Molecular Cancer Therapeutics Jan 2020, molcanther.0015.2020; DOI: 10.1158/1535-7163.MCT-20-0015
The indenoisoquinoline LMP517: a novel antitumor agent targeting both TOP1 and TOP2
Laetitia Marzi, Yilun Sun, Shar-Yin N. Huang, Amy James, Simone Difilippantonio, Yves Pommier

Molecular Cancer Therapeutics Jan 2020, molcanther.1064.2019; DOI: 10.1158/1535-7163.MCT-19-1064
Targeting casein kinase 1 delta sensitizes pancreatic and bladder cancer cells to gemcitabine treatment by upregulating deoxycytidine kinase
Francesca Vena, Simon Bayle, Ainhoa Nieto, Victor Quereda, Massimilliano Aceti, Sylvia M Frydman, Samer S. Sansil, Wayne Grant, Andrii Monastyrskyi, Patricia McDonald, William R. Roush, Mingxiang Teng, Derek Duckett

Molecular Cancer Therapeutics Jan 2020, molcanther.0997.2019; DOI: 10.1158/1535-7163.MCT-19-0997
Metabolic adaptations to MEK and CDK4/6 co-targeting in uveal melanoma
Jessica LF Teh, Timothy J. Purwin, Anna Han, Vivian Chua, Prem Patel, Usman Baqai, Connie Liao, Nelisa Bechtel, Takami Sato, Michael A. Davies, Julio A Aguirre-Ghiso, Andrew E. Aplin

Molecular Cancer Therapeutics Jan 2020, molcanther.1016.2019; DOI: 10.1158/1535-7163.MCT-19-1016
Combinatorial inhibition of focal adhesion kinase and BCL-2 enhances anti-leukemia activity of venetoclax in acute myeloid leukemia
Xiangmeng Wang, Po Yee Mak, Hong Mu, Wenjing Tao, Arvind Rao, Ravikumar Visweswaran, Vivian Ruvolo, Jonathan A. Pachter, David T. Weaver, Michael Andreeff, Bing Xu, Bing Z. Carter

Molecular Cancer Therapeutics Jan 2020, molcanther.0841.2019; DOI: 10.1158/1535-7163.MCT-19-0841
Preclinical characterization of an antibody-drug conjugate targeting CS-1 and the identification of uncharacterized populations of CS-1-positive cells
Ruoyan Chen, Saravanan Rajan, Michael G Overstreet, Elaine M. Hurt, Suneetha B Thomas, Vanessa Muniz-Medina, Christopher Ward, Agnieszka Sadowska, Ryan Fleming, Subramanya Karanth, Shannon Breen, Bo Zheng, Yuling Wu, William O. Iverson, Steven Novick, Terrence O'Day, Dipesha P Shah, Nazzareno Dimasi, Arnaud C Tiberghien, Jane Osbourn, Jill Walker

Molecular Cancer Therapeutics Jan 2020, molcanther.0482.2019; DOI: 10.1158/1535-7163.MCT-19-0482

Main menu

User menu

Search

More articles from Research Article

Pages

Articles

Info for

About MCT